OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumors resurrect an embryonic vascular program to escape immunity
Elisabeth J. M. Huijbers, Kabir A. Khan, Robert S. Kerbel, et al.
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Nucleolin promotes angiogenesis and endothelial metabolism along the oncofetal axis in the human brain vasculature
Marc Schwab, Ignazio de Trizio, Moheb Ghobrial, et al.
JCI Insight (2023) Vol. 8, Iss. 8
Open Access | Times Cited: 6

Glioblastoma Vascular Plasticity Limits Effector T-cell Infiltration and Is Blocked by cAMP Activation
Zixi Qin, Youwei Huang, Zeying Li, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 10, pp. 1351-1366
Closed Access | Times Cited: 6

Advanced in vitro models for renal cell carcinoma therapy design
Valentin Mieville, Arjan W. Griffioen, Daniel Benamran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188942-188942
Open Access | Times Cited: 5

Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
Amanda L. McCormick, Trevor S. Anderson, Elizabeth A. Daugherity, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4

Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapy
Zheng-Yu Qian, Yi‐Qian Pan, Xuexin Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 6, pp. 803-822
Open Access | Times Cited: 1

Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Valentin Benboubker, George M. Ramzy, S. Jacobs, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1

Tumor Environment Regression Therapy Implemented by Switchable Prune‐to‐Essence Nanoplatform Unleashed Systemic Immune Responses
Xianzhou Huang, Lu Li, Chunqing Ou, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 3

Hypoxia orchestrates the lymphovascular–immune ensemble in cancer
Luana Schito, Sergio Rey
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 771-784
Closed Access | Times Cited: 5

Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg-dependent CD8+T cell exclusion
Elen Torres-Mejia, Sally Weng, Kim Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Single-cell signatures identify microenvironment factors in tumors associated with patient outcomes
Yuanqing Xue, Verena Friedl, Hongxu Ding, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 6, pp. 100799-100799
Open Access

ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer
Lora Stojanovic, Rachel Abbotts, Kaushlendra Tripathi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Reversal of Endothelial Cell Anergy by T Cell-Engaging Bispecific Antibodies
Márcia Gonçalves, Karsten M. Warwas, Marten Meyer, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4251-4251
Open Access

Previous Page - Page 2

Scroll to top